SCIENTISTS ARE working at an unprecedented pace to find a vaccine for SARS-CoV-2, the virus that causes covid-19. The stakes are high. Natasha Loder, The Economist’s health policy editor, explains how an effective vaccine might be developed.
Dr Trevor Drew of the Australian Centre for Disease Preparedness speaks to host Kenneth Cukier about two trials which have reached the animal-testing stage. Plus, once a vaccine is discovered, what can be done to make sure it is distributed fairly? Dr Seth Berkely, chief executive of GAVI, the vaccine alliance, explains the importance of global cooperation. Runtime: 26 min

A selection of three essential articles read aloud from the latest issue of The Economist. This week, the




A hundred days after a Chinese government website announced the discovery of a “pneumonia of unknown cause”, it has become clearer that the dynamics behind the virus’s rapid expansion across the globe has relied heavily on such “cluster effects”.
Scientists around the world are racing to develop a vaccine for COVID-19. But experts have said it could take a year to 18 months for one to hit the market. The process for testing and approving a vaccine is long and complicated.